Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Transient Receptor Potential Vanilloid One (TRPV1) Receptor Expression in Children With Retrosternal Pain (TRPV1)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Manu Sood, Medical College of Wisconsin
ClinicalTrials.gov Identifier:
NCT00677378
First received: May 9, 2008
Last updated: October 21, 2015
Last verified: October 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2015
  Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)